Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $1.92 million in 9M 2016


According to the financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2016, Net profit after tax of the period reached 1,916,996 USD Compared with Net profit after tax 2,896,369 USD for 2015, a net decrease in profit of 33.81%.Total assets of the company reached 55,119,192 USD compared with total assets of 51,192,232 USD at the end of year 2015, a net increase of 7.67%.Total liabilities of the company reached 15,296,318 USD compared with total liabilities of 14,983,341 USD at the end of year 2015, a net increase of 2.08%. Net ownership equity of the company reached 39,822,874 USD (Including Non-Controlling Interests of 539,219 USD) compared with total owner equity of 36,208,891 USD (Including Non-Controlling Interests of 647,664 USD) at the end of year 2015, a net increase of 9.98%.Noting that paid-in capital increased from 17,060,000 USD in year 2015 to 18,000,000 USD of this year, a net increase of 5.51%.


Relative quietness in the PEX with the increasing anticipation for the annual disclosures

WATANIYA discusses raising its paid-up capital to $293 million

The PEX opens the year 2018 in optimism

The PEX modifies AL-Quds Index composition for the year 2018



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013